A. Tomonaga

Knowledge‐Based Identification of the ERK2/STAT3 Signal Pathway as a Therapeutic Target for Type 2 Diabetes and Drug Discovery

Shuhei Kinoshita, T. Kinoshita, K. Doi, 2011, Chemical biology & drug design.

Investigation of substrate specificity and regioselectivity based on enzyme and substrate three dimensional structure of CYP1A2 of human and animals

N. Kamiya, S. Hattori, Mutsuyo Wada, 2008 .

Molecular characterization of genetic mutations in human lactate dehydrogenase (LDH) B (H) variant

M. Maekawa, T. Kanno, K. Sudo, 1992, Human Genetics.

Identification of allosteric ERK2 inhibitors through in silico biased screening and competitive binding assay.

T. Kinoshita, N. Takahashi, H. Sugiyama, 2016, Bioorganic & medicinal chemistry letters.